NEW YORK – R-Biopharm of Darmstadt, Germany, has obtained the CE mark for its SARS-CoV-2 real-time RT-PCR test.
The company's Rida Gene SARS-CoV-2 test is designed for the qualitative detection of SARS-CoV-2 RNA from throat and nasopharyngeal swabs of individuals with respiratory symptoms. It runs on the Roche LightCycler 480II and is intended for use by professionals in hospital, reference, private, and state laboratories.